Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria
<p>Abstract</p> <p>Background</p> <p>Colorectal cancer is the third most-common cancer and the second most-common cause of cancer related death in UK. Although chemotherapy plays significant role in the treatment of colorectal cancer, morbidity and mortality due to drug...
Main Authors: | Sagar Jayesh, Sales Kevin, Taanman Jan-Willem, Dijk Sas, Winslet Marc |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/10/1/31 |
Similar Items
-
Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?
by: Taanman JanWillem, et al.
Published: (2009-01-01) -
Role of stem cells in cancer therapy and cancer stem cells: a review
by: Sales Kevin, et al.
Published: (2007-06-01) -
Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells
by: Ganesh Radhakrishnan, et al.
Published: (2012-09-01) -
A Mitochondria-Initiated Apoptotic Pathway
by: Xiaodong Wang
Published: (2001-01-01) -
Mitochondria-Associated endoplasmic reticulum Membranes (MAMs) microenvironment: targeting autophagic and apoptotic pathways in cancer therapy
by: Simone ePatergnani, et al.
Published: (2015-07-01)